Evidence map›Paper›PMID 36950087›Full record

ArticleOphthalmology science2023

Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy.

Yian Guo, Sean Yonamine, Chu Jian Ma, Jay M Stewart, Nisha Acharya, Benjamin F Arnold, Charles McCulloch, Catherine Q Sun

Abstract read
In one paragraph

Article in Ophthalmology science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yian GuoDepartment of Ophthalmology, University of California, San Francisco, California.
Sean YonamineDepartment of Ophthalmology, University of California, San Francisco, California.
Chu Jian MaDepartment of Ophthalmology, University of California, San Francisco, California.
Jay M StewartDepartment of Ophthalmology, University of California, San Francisco, California.
Nisha AcharyaDepartment of Ophthalmology, University of California, San Francisco, California.
Benjamin F ArnoldDepartment of Ophthalmology, University of California, San Francisco, California.
Charles McCullochDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California.
Catherine Q SunDepartment of Ophthalmology, University of California, San Francisco, California.

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 1985 to 2024
$16.8M
Real-world outcomes of proliferative diabetic retinopathyK23EY032637 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SUN, CATHERINE QING · 2021 to 2025
$1.3M
NEI NIH HHS K23 EY032637NEI NIH HHS P30 EY002162
6 · The paper itself

Abstract

Purpose: To develop models for progression of nonproliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR) and determine if incorporating updated information improves model performance. Design: Retrospective cohort study. Participants: Electronic health record (EHR) data from a tertiary academic center, University of California San Francisco (UCSF), and a safety-net hospital, Zuckerberg San Francisco General (ZSFG) Hospital were used to identify patients with a diagnosis of NPDR, age ≥ 18 years, a diagnosis of type 1 or 2 diabetes mellitus, ≥ 6 months of ophthalmology follow-up, and no prior diagnosis of PDR before the index date (date of first NPDR diagnosis in the EHR). Methods: Four survival models were developed: Cox proportional hazards, Cox with backward selection, Cox with LASSO regression and Random Survival Forest. For each model, three variable sets were compared to determine the impact of including updated clinical information: Static Main Outcome Measures: Time to PDR. Results: The UCSF cohort included 1130 patients and 92 (8.1%) patients progressed to PDR. The ZSFG cohort included 687 patients and 30 (4.4%) patients progressed to PDR. All models performed similarly (C-indices ∼ 0.70) in internal validation. The random survival forest with Static Conclusions: Our models for progression of NPDR to PDR achieved acceptable predictive performance and validated well in an external setting. Updating the baseline variables with new clinical information did not consistently improve the predictive performance. Financial Disclosures: Proprietary or commercial disclosure may be found after the references.

Indexed as

C-index, Harrell’s Concordance indexCox-BW, Cox with backward selectionCox, Cox proportional hazards regressionCox-LS, Cox with LASSO regressionDM, diabetes mellitusEHR, electronic health recordHbA1c, hemoglobin A1cICD, International Classification of DiseasesNonproliferative diabetic retinopathyNPDR, nonproliferative diabetic retinopathyPDR, prolifterative diabetic retinopathyPredictionProliferative diabetic retinopathyRSF, random survival forestTime-to-event modelsUCSF, University of California San Franciscovs., versusZSFG, Zuckerberg San Francisco General

Identifiers

PMID36950087
PMCPMC10025270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.